4Kscore Test Results Significantly Influenced Physician-Patient Shared Decision-Making in Clinical Practice and Led to a 64.6% Reduction in Prostate Biopsies MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NYSE: OPK) announced today the results of a study for the 4Kscore® Test’s clinical utility in reducing the number of prostate biopsies performed, while increasing the probability of detecting aggressive prostate cancer […]
Search Results for: ACT 1 test
MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NYSE:OPK) announced today that the American Medical Association (AMA) Current Procedural Terminology (CPT®) Editorial Panel has granted a Category I CPT code for its 4Kscore® Test, the only blood test that accurately identifies an individual patient’s risk for aggressive prostate cancer. This important event upgrades the 4Kscore Test from a Category III Administrative code to a […]
MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NYSE:OPK) today announced that it has entered into agreements with Stratose, Three Rivers Provider Network and Fortified Provider Network for testing services from OPKO Lab, including the 4Kscore®Test, the only blood test that accurately identifies an individual patient’s risk for high-grade, aggressive cancer. The cumulative contracts, with some of the largest healthcare PPO network […]
11
Apr
Apr
April 14 to April 20, 2024 The Future Is Lab Every single day, the work of laboratory professionals and pathologists is instrumental in healthcare and the delivery of patient care. Their diagnostic testing, performed in the lab, is a crucial part of the healthcare process. The 49th Annual Lab Week is sponsored by the American […]
PR Newswire Transaction to enhance Labcorp’s laboratory services network and expand access to the company’s high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI, March 28, 2024 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select […]
07
Mar
Mar
March is National Colorectal Cancer Awareness Month, a time to come together to raise awareness about the importance of early detection and prevention of colorectal cancer. This month presents an opportunity to promote and market the offerings of BioReference Health in the field of colorectal cancer care. At BioReference, we are dedicated to advancing oncology […]
26
Oct
Oct
According to the National Down syndrome Society, in the US, 1 in 772 live births result in a Down syndrome diagnosis, making Down syndrome the most common chromosomal condition. The month of October is Down Syndrome Awareness Month, giving families, individuals, and patients the opportunity to share information about the condition, learn more, and contribute […]
23
Oct
Oct
It’s October and Breast Cancer Awareness Month! Remember to monitor your breast health and speak to your healthcare provider about screenings including genetic testing for hereditary breast cancer.
26
Sep
Sep
The Foundation for Women’s Cancer states that every five minutes, a woman will be diagnosed with one of the five main gynecological cancers. Bring awareness to the importance of prevention, knowing symptoms and risk profiles of women, and understanding the various types of cancer during the month of September for Gynecologic Cancer Awareness Month.
